61R Stock Chart & Stats
€4.74
€0.12(2.75%)
At close: 4:00 PM EST
€4.74
€0.12(2.75%)
Day’s Range― - ―
52-Week Range€3.73 - €5.55
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€13.11M
Enterprise Value€3.43M
Total Cash (Recent Filing)€16.67M
Total Debt (Recent Filing)€6.11M
Price to Earnings (P/E)―
Beta0.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding2,886,754
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.87
Price to Book (P/B)0.68
Price to Sales (P/S)0.28
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.44
Revenue Forecast (FY)€39.40M
Euromedis Groupe SA News
61R FAQ
What was Euromedis Groupe SA’s price range in the past 12 months?
Euromedis Groupe SA lowest stock price was €3.73 and its highest was €5.55 in the past 12 months.
What is Euromedis Groupe SA’s market cap?
Euromedis Groupe SA’s market cap is €13.11M.
When is Euromedis Groupe SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Euromedis Groupe SA’s earnings last quarter?
Euromedis Groupe SA released its earnings results on Sep 30, 2021. The company reported €1.402 earnings per share for the quarter, beating the consensus estimate of N/A by €1.402.
Is Euromedis Groupe SA overvalued?
According to Wall Street analysts Euromedis Groupe SA’s price is currently Overvalued.
Does Euromedis Groupe SA pay dividends?
Euromedis Groupe SA does not currently pay dividends.
What is Euromedis Groupe SA’s EPS estimate?
Euromedis Groupe SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Euromedis Groupe SA have?
Euromedis Groupe SA has 2,886,754 shares outstanding.
What happened to Euromedis Groupe SA’s price movement after its last earnings report?
Euromedis Groupe SA reported an EPS of €1.402 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Euromedis Groupe SA?
Currently, no hedge funds are holding shares in DE:61R
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Euromedis Groupe SA
Euromedis Groupe, a French company established in 1985 and based in Mouy, France, specializes in the development, manufacturing, and distribution of medical equipment. Operating under its proprietary Euromedis brand, the company caters to a broad clientele in France, including medical professionals, local public services, and private individuals. Its extensive product line encompasses a wide array of medical supplies. This includes sterile and non-sterile gloves, wound care essentials like dressings and compresses, and various medical kits. For parenteral care, it provides items such as needles, syringes, infusers, and catheters. The surgical range is comprehensive, featuring wound drainage products, probes, draping solutions for operating theaters, surgical gloves, and protective covers. Beyond these, Euromedis also offers oxygen therapy equipment, products for continence management and general hygiene, diagnostic tools, and a selection of home care necessities. In addition to its product offerings, Euromedis Groupe provides services such as the distribution and rental of medical equipment, as well as specialized in-home infusion and nutrition support. While primarily focused on the French market, the company has a significant international footprint, exporting its products to numerous countries including Belgium, Italy, Morocco, Ivory Coast, Gabon, Benin, Algeria, Ireland, the Netherlands, Portugal, Tunisia, Switzerland, the Czech Republic, the United Kingdom, Germany, Finland, Spain, Greece, Hungary, Lithuania, Latvia, Bulgaria, and Poland.
Technical Analysis
MAUNA KEA TECHNOLOGIES
―
Novacyt
―
Eurobio-Scientific SA
―
Diagnostic Medical Systems
―
Bluelinea SA
―

